ASCEND BY NTHRYS
Research Abroad Products

Cancer Systems Biology Project Topics

Browse all focused areas across all project categories under this field.

Showing 85–96 of 200 project topics
Clinical-Grade Mutation Signature Profiling Service Platform
A CLIA-certified, automated platform that identifies cancer mutational signatures linked to specific carcinogenic exposures and DNA repair deficiencies. Delivers revenue through clinical testing services, insurance billing, and licensing of signature databases to diagnostic providers.
Cancer Systems Biology Biomarker Discovery Services Click to view more details →
Patient Stratification Tool for Precision Oncology Clinical Trials
A biomarker-driven software solution that identifies eligible patients for targeted cancer trials based on molecular profiles and predicted treatment response. Accelerates patient recruitment and enrollment for pharma sponsors, reducing trial timelines and generating service fees.
Cancer Systems Biology Biomarker Discovery Services Click to view more details →
Resistance Mutation Detection Platform for Therapy Optimization
An NGS-integrated platform that identifies emerging resistance mutations in real-time to guide treatment switches before clinical progression. Creates competitive advantage for oncology centers and generates recurring subscription revenue through continuous monitoring services.
Cancer Systems Biology Biomarker Discovery Services Click to view more details →
Immunogenicity Prediction Tool for Personalized Cancer Vaccines
A computational platform that predicts neoantigen immunogenicity and patient HLA-peptide binding to optimize personalized tumor vaccine design. Enables biotech companies to streamline therapeutic development and unlock licensing partnerships with major pharmaceutical firms.
Cancer Systems Biology Biomarker Discovery Services Click to view more details →
Cancer Biomarker Knowledge Graph and Discovery API
A commercial API and database aggregating validated cancer biomarkers, molecular associations, and clinical outcomes across tumor types. Generates B2B SaaS revenue through API subscriptions, white-label licensing, and integration with electronic health record systems.
Cancer Systems Biology Biomarker Discovery Services Click to view more details →
Minimal Residual Disease Monitoring Dashboard for Oncology Clinics
A real-time clinical dashboard platform that tracks circulating tumor DNA and protein biomarkers to detect minimal residual disease post-treatment. Creates recurring revenue through clinic subscriptions while improving patient surveillance and enabling earlier intervention.
Cancer Systems Biology Biomarker Discovery Services Click to view more details →
AI-Powered Genomic Tumor Classification Engine Platform
A SaaS platform that integrates whole genome sequencing data with machine learning algorithms to automatically classify tumors into molecularly-defined subtypes and predict treatment response. This delivers recurring revenue through subscription licensing to oncology labs and hospitals while reducing diagnostic turnaround time from weeks to days.
Cancer Systems Biology Patient Stratification Tools Click to view more details →
Real-Time Patient Risk Stratification Dashboard for Oncology
A web-based clinical decision support tool that aggregates multi-omics data, medical history, and imaging to generate patient-specific risk scores and treatment recommendations in real-time. The platform enables precision oncology practices to justify premium care models and increase patient enrollment in high-value treatment protocols.
Cancer Systems Biology Patient Stratification Tools Click to view more details →
Immune Microenvironment Profiling SaaS for Immunotherapy Selection
A cloud-based analysis service that quantifies immune cell infiltration, checkpoint expression, and T-cell clonality from tissue samples to predict immunotherapy response rates. This service generates revenue through per-sample fees and partnerships with pharmaceutical companies running immuno-oncology trials.
Cancer Systems Biology Patient Stratification Tools Click to view more details →
Mutation Burden and Neoantigen Prediction Commercial Tool Suite
A proprietary software platform that rapidly calculates tumor mutational burden and predicts immunogenic neoantigens from sequencing data to inform checkpoint inhibitor and personalized vaccine strategies. Revenue streams include licensing fees to biopharma firms, clinical laboratory partnerships, and integration into electronic health records systems.
Cancer Systems Biology Patient Stratification Tools Click to view more details →
Multi-Omics Integration Platform for Precision Oncology Centers
An enterprise software solution that consolidates genomics, proteomics, metabolomics, and clinical data into a unified patient profile for comprehensive cancer stratification. The platform monetizes through institutional licensing, professional services implementation, and licensing to academic medical centers seeking precision medicine capabilities.
Cancer Systems Biology Patient Stratification Tools Click to view more details →
Liquid Biopsy Data Analytics Platform for Early Detection Markets
A specialized analytics engine that interprets circulating tumor DNA, cell-free RNA, and exosome profiles to stratify patients by cancer risk and stage of disease progression. This tool addresses the multi-billion-dollar early cancer detection market and generates revenue through test fees and partnerships with diagnostic companies.
Cancer Systems Biology Patient Stratification Tools Click to view more details →